Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKinsey
Boehringer Ingelheim
McKesson
Mallinckrodt

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rifaximin


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

rifaximin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Salix Pharms XIFAXAN rifaximin TABLET;ORAL 021361 NDA Cardinal Health 55154-6777-8 360 TABLET in 1 BOTTLE, PLASTIC (55154-6777-8)
Salix Pharms XIFAXAN rifaximin TABLET;ORAL 021361 NDA Salix Pharmaceuticals, Inc. 65649-301-03 30 TABLET in 1 BOTTLE (65649-301-03)
Salix Pharms XIFAXAN rifaximin TABLET;ORAL 021361 NDA Salix Pharmaceuticals, Inc. 65649-301-05 10 BLISTER PACK in 1 CARTON (65649-301-05) > 10 TABLET in 1 BLISTER PACK
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Baxter
Moodys
Dow
AstraZeneca